Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A GALLOWAY

Showing results (361-370 of 400) with videos related to

Pageof 40
Sort By:
In Vitro Cellular & Developmental Biology. Animal|January 1, 1997
Generation of a human melanocyte cell line by introduction of HPV16 E6 and E7 genesI C Le Poole, F M van den Berg, R M van den Wijngaard, et al.
Annals of the New York Academy of Sciences|July 23, 1999
Preclinical and clinical studies of MMP inhibitors in cancerA H Drummond, P Beckett, P D Brown, et al.
Cancer Causes & Control : CCC|September 30, 2015
Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case-control studyDanny V Colombara, Lisa E Manhart, Joseph J Carter, et al.
Journal of Clinical Pathology|January 31, 2006
Best practice in primary care pathology: review 2W S Smellie, J O Forth, C A M McNulty, et al.
Journal of the National Cancer Institute|September 25, 2009
Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinomaJoseph J Carter, Kelly G Paulson, Greg C Wipf, et al.
International Journal of Cancer|April 13, 2005
Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive diseaseJanet R Daling, Margaret M Madeleine, Lisa G Johnson, et al.
Cancer Research|September 10, 1998
Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variantsL F Xi, C W Critchlow, C M Wheeler, et al.
Plos Pathogens|October 21, 2025
Human monoclonal antibodies to HPV16 show evidence for common developmental pathways and public epitopesJoseph J Carter, Nicholas K Hurlburt, Erin M Scherer, et al.
Journal of Immunological Methods|October 18, 2020
Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodiesRachael E Whaley, Sarah Ameny, Tanvi Arkatkar, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
HPV16 neutralizing monoclonal antibodies show evidence for common developmental pathways and public epitopesJoseph J Carter, Nicholas K Hurlburt, Erin M Scherer, et al.
Pageof 40

Showing results (361-370 of 400) with videos related to

Sort By:
Pageof 40
In Vitro Cellular & Developmental Biology. Animal|January 1, 1997
Generation of a human melanocyte cell line by introduction of HPV16 E6 and E7 genesI C Le Poole, F M van den Berg, R M van den Wijngaard, et al.
Annals of the New York Academy of Sciences|July 23, 1999
Preclinical and clinical studies of MMP inhibitors in cancerA H Drummond, P Beckett, P D Brown, et al.
Cancer Causes & Control : CCC|September 30, 2015
Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case-control studyDanny V Colombara, Lisa E Manhart, Joseph J Carter, et al.
Journal of Clinical Pathology|January 31, 2006
Best practice in primary care pathology: review 2W S Smellie, J O Forth, C A M McNulty, et al.
Journal of the National Cancer Institute|September 25, 2009
Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinomaJoseph J Carter, Kelly G Paulson, Greg C Wipf, et al.
International Journal of Cancer|April 13, 2005
Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive diseaseJanet R Daling, Margaret M Madeleine, Lisa G Johnson, et al.
Cancer Research|September 10, 1998
Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variantsL F Xi, C W Critchlow, C M Wheeler, et al.
Plos Pathogens|October 21, 2025
Human monoclonal antibodies to HPV16 show evidence for common developmental pathways and public epitopesJoseph J Carter, Nicholas K Hurlburt, Erin M Scherer, et al.
Journal of Immunological Methods|October 18, 2020
Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodiesRachael E Whaley, Sarah Ameny, Tanvi Arkatkar, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
HPV16 neutralizing monoclonal antibodies show evidence for common developmental pathways and public epitopesJoseph J Carter, Nicholas K Hurlburt, Erin M Scherer, et al.
Pageof 40